Perioperative venous thromboembolism in patients with gynecological malignancies: A lesson from four years of recent clinical experience

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3589-3595

  Morimoto, Akiko ^a   Ueda, Yutaka ^a   Yokoi, Takeshi ^b   Tokizawa, Yuki ^a   Yoshino, Kiyoshi ^a   Fujita, Masami ^a   Kimura, Toshihiro ^a   Kobayashi, Eiji ^a   Matsuzaki, Shinya ^a   Egawa Takata, Tomomi ^a   Sawada, Kenjiro ^a   Tsutsui, Tateki ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kaizuka City Hospital   (Japan)

Author keywords

Economic comparison; Fondaparinux; Gynecological malignancy; Post operative; Prophylaxis; Short duration; UFH; VTE

Indexed keywords

ENOXAPARIN; FONDAPARINUX; HEPARIN; WARFARIN; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; POLYSACCHARIDE;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER PATIENT; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; OPERATION DURATION; OVARY CANCER; PELVIS LYMPHADENECTOMY; PERIOPERATIVE PERIOD; RISK FACTOR; THROMBOSIS PREVENTION; UTERINE CERVIX CANCER; VENOUS THROMBOEMBOLISM; BLOOD; COST BENEFIT ANALYSIS; ECONOMIC COMPARISON; ECONOMICS; FEMALE GENITAL TRACT TUMOR; GYNECOLOGICAL MALIGNANCY; JAPAN; MIDDLE AGED; POST-OPERATIVE; PROPHYLAXIS; SHORT DURATION; UFH; VERY ELDERLY; VTE;

ECONOMIC COMPARISON; FONDAPARINUX; GYNECOLOGICAL MALIGNANCY; POST-OPERATIVE; PROPHYLAXIS; SHORT DURATION; UFH; VTE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COST-BENEFIT ANALYSIS; FEMALE; GENITAL NEOPLASMS, FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; JAPAN; MIDDLE AGED; PERIOPERATIVE PERIOD; POLYSACCHARIDES; VENOUS THROMBOEMBOLISM;

EID: 84906309010     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dainty L, Maxwell GL, Clarke-Pearson DL and Myers ER: Costeffectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Gynecol Oncol 93: 366-373, 2004.
2. Einstein MH, Kushner DM, Connor JP, Bohl AA, Best TJ, Evans MD, Chappell RJ and Hartenbach EM: A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients. Obstet Gynecol 112: 1091-1097, 2008.
3. Matsuura Y, Robertson G, Marsden DE, Kim SN, Gebski V and Hacker NF: Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104: 406-410, 2007.
4. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D and White RH: Venous thromboembolism in ovarian cancer. Gynecol Oncol 105: 784-790, 2007.
5. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos AC and Piovella F: Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 99: 119-125, 2005.
6. Wang X, Fu S, Freedman RS and Kavanagh JJ: Venous thromboembolism syndrome in gynecological cancer. Int J Gynecol Cancer 16(Suppl 1): 458-471, 2006.
7. Teoh D, Berchuck A, Alvarez Secord A, Lee PS, Lowery WJ, Sfakianos GP, Valea FA, Myers ER and Havrilesky LJ: Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. Gynecol Oncol 122: 467-472, 2011.
8. Clarke-Pearson DL and Abaid LN: Prevention of venous thromboembolic events after gynecologic surgery. Obstet Gynecol 119: 155-167, 2012.
9. Clagett GP and Reisch JS: Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 208: 227-240, 1988.
10. Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D and Decousus H: Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 83: 14-19, 2000.
11. Agnelli G, Bergqvist D, Cohen AT, Gallus AS and Gent M: Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92: 1212-1220, 2005.
12. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D and Francis CW: American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25: 5490-5505, 2007.
13. Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M, Vandvik PO, Eikelboom JW, McDonagh MS, Lewis SZ, Gutterman DD, Cook DJ and Schunemann HJ: Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: 53S-70S, 2012.
14. Khorana AA: The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist 12: 1361-1370, 2007.
15. Arcelus JI, Villar JM and Munoz N: Should we follow the 9th ACCP guidelines for VTE prevention in surgical patients? Thromb Res 130(Suppl 1): S4-6, 2012.
16. Peedicayil A, Weaver A, Li X, Carey E, Cliby W and Mariani A: Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol 121: 64-69, 2011.
17. Okadome M, Saito T, Miyahara D, Yamanaka T, Kuroiwa T and Kurihara Y: Postoperative pulmonary embolism including asymptomatic cases in gynecologic oncology. Int J Gynecol Cancer 20: 655-663, 2010.
18. Gordois A, Posnett J, Borris L, Bossuyt P, Jonsson B, Levy E and de Pouvourville G: The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery. J Thromb Haemost 1: 2167-2174, 2003.
19. Ueda Y, Enomoto T, Miyatake T, Egawa-Takata T, Ugaki H, Yoshino K, Fujita M and Kimura T: Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery. Ann Surg Oncol 17: 1111-1117, 2010.
20. Ugaki H, Enomoto T, Fujiwara K, Kimura T and Kawasaki T: Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population. Blood Coagul Fibrinolysis 19: 585-589, 2008.